These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 6119918)

  • 21. Pitfalls and prospects in clinical research on antianxiety drugs: benzodiazepines and placebo--a research review.
    Solomon K; Hart R
    J Clin Psychiatry; 1978 Nov; 39(11):823-31. PubMed ID: 31354
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Switching from benzodiazepines to buspirone using a tapered overlap method in generalized anxiety disorder.
    Arató M
    J Clin Psychiatry; 2001 Aug; 62(8):657-8. PubMed ID: 11561943
    [No Abstract]   [Full Text] [Related]  

  • 23. Buspirone: multicenter efficacy study.
    Wheatley D
    J Clin Psychiatry; 1982 Dec; 43(12 Pt 2):92-4. PubMed ID: 6130079
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Efficacy of diazepam as an anti-anxiety agent: meta-analysis of double-blind, randomized controlled trials carried out in Japan.
    Inada T; Nozaki S; Inagaki A; Furukawa TA
    Hum Psychopharmacol; 2003 Aug; 18(6):483-7. PubMed ID: 12923829
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Double-blind, placebo-controlled trial of two doses of abecarnil for geriatric anxiety.
    Small GW; Bystritsky A
    J Clin Psychiatry; 1997; 58 Suppl 11():24-9. PubMed ID: 9363045
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Bromazepam and diazepam in generalized anxiety: a placebo-controlled study of efficacy and withdrawal.
    Fontaine R; Chouinard G; Annable L
    Psychopharmacol Bull; 1984; 20(1):126-7. PubMed ID: 6144130
    [No Abstract]   [Full Text] [Related]  

  • 27. Alprazolam and diazepam in the treatment of generalized anxiety.
    Elie R; Lamontagne Y
    J Clin Psychopharmacol; 1984 Jun; 4(3):125-9. PubMed ID: 6145726
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A double-blind evaluation of the safety and efficacy of abecarnil, alprazolam, and placebo in outpatients with generalized anxiety disorder. Abecarnil Work Group.
    Lydiard RB; Ballenger JC; Rickels K
    J Clin Psychiatry; 1997; 58 Suppl 11():11-8. PubMed ID: 9363043
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Bromazepam and diazepam in generalized anxiety: a placebo-controlled study with measurement of drug plasma concentrations.
    Fontaine R; Annable L; Chouinard G; Ogilvie RI
    J Clin Psychopharmacol; 1983 Apr; 3(2):80-7. PubMed ID: 6132936
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A double blind comparison of ketazolam given once each day with diazepam given in divided doses and placebo in the treatment of anxiety.
    Br J Clin Pract; 1980 Apr; 34(4):107-13. PubMed ID: 6104979
    [No Abstract]   [Full Text] [Related]  

  • 31. Deramciclane in the treatment of generalized anxiety disorder: a placebo-controlled, double-blind, dose-finding study.
    Naukkarinen H; Raassina R; Penttinen J; Ahokas A; Jokinen R; Koponen H; Lepola U; Kanerva H; Lehtonen L; Pohjalainen T; Partanen A; Mäki-Ikola O; Rouru J;
    Eur Neuropsychopharmacol; 2005 Dec; 15(6):617-23. PubMed ID: 15949921
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A double-blind, placebo-controlled study comparing the efficacy and safety of ipsapirone versus lorazepam in patients with generalized anxiety disorder: a prospective multicenter trial.
    Cutler NR; Sramek JJ; Keppel Hesselink JM; Krol A; Roeschen J; Rickels K; Schweizer E
    J Clin Psychopharmacol; 1993 Dec; 13(6):429-37. PubMed ID: 7907097
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Development of a patient-reported assessment to identify placebo responders in a generalized anxiety disorder trial.
    Feltner D; Hill C; Lenderking W; Williams V; Morlock R
    J Psychiatr Res; 2009 Oct; 43(15):1224-30. PubMed ID: 19423131
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Double blind comparative clinical evaluation of a new anxiolytic agent, Zami-905: propazepam].
    Carbonell Masía DC; Calvé Pérez A
    Actas Luso Esp Neurol Psiquiatr Cienc Afines; 1976; 4(6):377-86. PubMed ID: 19933
    [No Abstract]   [Full Text] [Related]  

  • 35. [Comparative double-blind clinical trial of SB 5833 and temazapam].
    Porta V; Jann G; Delzanno GB
    Brux Med; 1974 Nov; 54(11):655-8. PubMed ID: 4155344
    [No Abstract]   [Full Text] [Related]  

  • 36. Tiagabine in adult patients with generalized anxiety disorder: results from 3 randomized, double-blind, placebo-controlled, parallel-group studies.
    Pollack MH; Tiller J; Xie F; Trivedi MH
    J Clin Psychopharmacol; 2008 Jun; 28(3):308-16. PubMed ID: 18480688
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Placebo effect and relief of anxiety].
    Olié JP; Vanelle JM
    Encephale; 1983; 9(4 Suppl 2):231B-235B. PubMed ID: 6144518
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Anxiety disorders. Part 2: Pharmacotherapy with benzodiazepines.
    Labelle A; Lapierre YD
    Can Fam Physician; 1993 Oct; 39():2205-8; 2211-3. PubMed ID: 8106034
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Bromazepam(Lexotan) and chlorprothixene(Taractan) in psychoneurotic anxiety states. A randomized, double-blind study from general practice concerning the effect, drug consumption, and risk of repeated treatment].
    Fynboe C; Christensen N; Halberg T; Hansen EA; Holm P; Knudsen JP; Lindhardt J; Maul B; Musaeus C; Nielsen MT; Schaumburg E
    Ugeskr Laeger; 1981 Oct; 143(41):2641-5. PubMed ID: 6117963
    [No Abstract]   [Full Text] [Related]  

  • 40. Controlled clinical and quantitative EEG studies of triflubazam (ORF 8063) in patients with anxiety syndrome.
    Itil TM; Akpinar S; Fink M; Polvan N; Huque M; Sungurbey K
    Curr Ther Res Clin Exp; 1976 Mar; 19(3):307-15. PubMed ID: 5248
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.